Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition following Inducible Expression of Snail-1  by Javaid, Sarah et al.
Cell Reports
ArticleDynamic Chromatin Modification
Sustains Epithelial-Mesenchymal Transition
following Inducible Expression of Snail-1
Sarah Javaid,1,7 Jianmin Zhang,1,3,6,7 Endre Anderssen,1 Josh C. Black,1 Ben S. Wittner,1 Ken Tajima,1 David T. Ting,1
Gromoslaw A. Smolen,1,4 Matthew Zubrowski,1,5 Rushil Desai,1 Shyamala Maheswaran,1 Sridhar Ramaswamy,1
Johnathan R. Whetstine,1 and Daniel A. Haber1,2,*
1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA
2Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA
3Present address: Roswell Park Memorial Cancer Institute, Buffalo, NY 14263, USA
4Present address: Agios Pharmaceuticals, Cambridge, MA 02139, USA
5Present address: Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA
6Present address: The First Affiliated Hospital of Xi’an Jiaotong University, 710061 Shaanxi, China
7These authors contributed equally to this work
*Correspondence: haber@helix.mgh.harvard.edu
http://dx.doi.org/10.1016/j.celrep.2013.11.034
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works
License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are
credited.SUMMARY
Epithelial-mesenchymal transition (EMT) is thought
to contribute to cancer metastasis, but its underlying
mechanisms are not well understood. To define early
steps in this cellular transformation, we analyzed
human mammary epithelial cells with tightly regu-
lated expression of Snail-1, a master regulator of
EMT. After Snail-1 induction, epithelial markers
were repressed within 6 hr, and mesenchymal genes
were induced at 24 hr. Snail-1 binding to its target
promoters was transient (6–48 hr) despite continued
protein expression, and it was followed by both tran-
sient and long-lasting chromatin changes. Pharma-
cological inhibition of selected histone acetylation
and demethylation pathways suppressed the induc-
tion as well as the maintenance of Snail-1-mediated
EMT. Thus, EMT involves an epigenetic switch that
may be prevented or reversed with the use of
small-molecule inhibitors of chromatin modifiers.INTRODUCTION
The ability of cells to cycle between epithelial and mesenchymal
states is critical for normal development. While mesenchymal-
to-epithelial transition (MET) is required for renal epithelial
differentiation in response to signals from the ureteric bud,
epithelial-to-mesenchymal transition (EMT) is essential for the
development of melanocytes, heart valves, and neural-crest-
derived tissues (Thiery et al., 2009). The aberrant acquisition by
epithelial cells of mesenchymal features, including loss of
apico-basal polarity, increased migratory potential, and resis-
tance to apoptotic stimuli, has been implicated in models ofCell Recancer invasion and metastasis (Nieto, 2011). Moreover, shared
characteristics between cells subjected to EMT and stem or pro-
genitor cell populations have raised the possibility that both
involve fundamental properties involved in cell differentiation
and regenerative potential (Mani et al., 2008).
Despite the dramatic changes associated with EMT, the
mechanisms underlying this phenomenon are only partially un-
derstood. In nontransformed epithelial cells, prolonged (7 days)
exposure to transforming growth factor b (TGF-b) is required to
trigger loss of epithelial markers, such as E-cadherin and
EpCAM, and induce expression of mesenchymal markers,
including Vimentin and N-cadherin (Leivonen and Ka¨ha¨ri,
2007). Additional growth factors implicated in triggering EMT
include epidermal growth factor, hepatocyte growth factor,
platelet-derived growth factor, insulin growth factor, and Wnt
(Scheel and Weinberg, 2011, Thiery and Sleeman, 2006, Yang
and Weinberg, 2008). Downstream of these signaling molecules
are a set of transcriptional regulators, including Twist, Snail-1,
Slug, Zeb1, and Sip1 (Peinado et al., 2007), whose expression
is sufficient to induce EMT in epithelial cells. We recently identi-
fied a developmentally regulated transcription factor, LBX1, that
itself regulates TGF-b2, Snail-1, Zeb1, and Sip1 (Yu et al., 2009).
MicroRNAs, namely, the miR-200 family and miR-205, have
been shown to regulate EMT by targeting Zeb1 and Sip1 (Greg-
ory et al., 2008, Korpal and Kang, 2008). Thus, the induction and
maintenance of EMT may involve the coordination of multiple
regulatory components whose integration is key for this pro-
found change in cell fate.
A number of distinct mechanisms may underlie the integra-
tion of complex cellular signals resulting in EMT. Scheel et al.
(2011) proposed that autocrine BMP and Wnt signaling
may establish self-sustaining feedback loops that are sufficient
to induce and maintain the EMT state. Suppression of the
epithelial marker E-cadherin is itself capable of triggering EMT,
suggesting another feedback pathway involving the loss ofports 5, 1679–1689, December 26, 2013 ª2013 The Authors 1679
cell-surface-mediated signaling (Onder et al., 2008). Alterna-
tively, EMTmay result from a global chromatin switch, analogous
to other cell-fate changes that arise during physiological devel-
opment. Indeed, global chromatin modifications have been
noted under specific conditions, such as hypoxia-induced EMT
in the FADU epithelial cell line or TGF-b-induced EMT in mouse
hepatocytes (McDonald et al., 2011, Wu et al., 2011). Given the
presumed role of EMT in cancer progression, defining the mech-
anisms that sustain this phenotype in cancer cells may provide
important therapeutic opportunities.
Snail family members encode zinc-finger-type transcription
factors that induce EMT during mesoderm and neural crest for-
mation (Blanco et al., 2002). The prototype Snail-1 mediates
transcriptional repression of E-cadherin and other epithelial
markers, such as claudins, cytokeratins, mucins, plakophilin,
occludin, and ZO proteins (Batlle et al., 2000, Cano et al.,
2000, Thiery et al., 2009), binding to E-box consensus se-
quences and recruiting chromatin modifiers, including SIN3A,
histone deacetylase 1 (HDAC1), HDAC2, lysine-specific deme-
thylase 1 (LSD1), and components of the Polycomb-2 complex
(Herranz et al., 2008, Peinado et al., 2004). Here, we used tightly
regulated inducible expression of Snail-1 to trigger EMT and
measure the temporal pattern of immediate transcriptional and
chromatin changes. We find that Snail-1 binds transiently to its
target promoters, triggering transient and long-lasting chromatin
changes that appear to underlie EMT. Small-molecule inhibitors
of HDACs and LSD1/LSD2 suppress Snail-1-induced EMT and
may point the way toward pharmacological approaches to
reverse EMT in cancer.
RESULTS
Inducible Snail-1 Induction Leads to EMT
To generate a potent reversible EMT-inducing stimulus, we
created a Snail-1 retroviral expression construct using a fused
estrogen receptor (ER) response element to mediate regulation
by exogenous 4-hydroxy-tamoxifen (4-OHT). Since Snail-1 pro-
tein stability and nuclear localization are suppressed by GSK3-
b-mediated phosphorylation, we substituted the six targeted
amino acids (ER-Snail-16SA), thus conferring constitutive activity
to the induced protein (Zhou et al., 2004). Infection of nontrans-
formed, immortalized human mammary epithelial MCF10A cells
with ER-Snail-16SA, followed by treatment with 4-OHT, triggered
morphological and biomarker characteristics of EMT (Figures 1A
and 1B). A similar phenotype was induced in MCF7 human
breast adenocarcinoma cells (Figure S1A), and no such effect
was observed using the retroviral construct in the absence of
4-OHT (data not shown), or by 4-OHT alone in noninfected cells
(Figure S1B). In contrast to most model systems, which involve
prolonged exposure to TGF-b or ectopic Snail-1, the rapid induc-
tion of EMT made it possible to dissect the relative timing of
key characteristics, including increased cell migration, loss of
epithelial markers, and induction of mesenchymal markers.
As expected, Snail-1 induction resulted in loss of epithelial
markers (i.e., CDH1 and CDH3) and gain of mesenchymal
markers (i.e., FN1 and SERPINE1), detected at both RNA and
protein levels (Figures 1B–1E). Epithelial gene repression was
evident as early as 6 hr after 4-OHT treatment, whereas induction1680 Cell Reports 5, 1679–1689, December 26, 2013 ª2013 The Autof mesenchymal transcripts did not start until 24 hr after Snail-1
activation (Figures 1D and 1E). A comparable, albeit delayed,
time course of epithelial gene repression and mesenchymal
gene induction was evident in EMT induced by TGF-b (Figures
S1C and S1D). Increased cell migration, a key EMT-associated
phenotype linked to cancer metastasis, was virtually immediate
following Snail-1 induction. Indeed, by measuring real-time cell
migration, we observed increased migration of MCF10A cells
as early as 4 hr following 4-OHT treatment, with a continuous
rise in cell motility accompanying continued Snail-1 induction
(Figures 1F and S1E). Decreased cell proliferation, another
phenotype associated with EMT (Vega et al., 2004), was evident
as early as 24 hr (Figure S1F).
Dynamic Patterns of Gene Expression Associated with
Induction of EMT
The acute initiation of EMT by inducible Snail-1 made it possible
to identify a timeline of transcriptional changes that are integral
to this cellular transformation. Microarray-based expression
profiling combined with principal component analysis (PCA) re-
vealed a time-dependent connectivity pattern as cells pro-
gressed from epithelial to mesenchymal states (Figure 2A). Early
time points (3, 6, and 12 hr) were clustered together, marking the
immediate response to Snail-1. Thereafter, cells progressed
toward an intermediate state (24 and 72 hr) and a fully mesen-
chymal state (120 hr; Figure 2A).
We identified six distinct classes of Snail-1-dependent tran-
scripts: cluster I, transcripts repressed early (<24 hr, n = 712
transcripts); cluster II, transcripts repressed late (>24 hr, n =
503); cluster III, transiently repressed transcripts (between 6
and 72 hr, n = 24); cluster IV, transcripts induced early (<24 hr,
n = 363); cluster V, transcripts induced late (>24 hr, n = 1716);
and cluster VI, transiently induced transcripts (between 6 and
72 hr, n = 64; Figure 2B; Tables S1–S6). Characteristic epithelial
markers, such as CDH1 and OCLDN, were suppressed early
(cluster I). Although less immediate in their Snail-1-driven induc-
tion, characteristic mesenchymal markers, including FN1 and
CTGF, were among the early-induced transcripts (cluster IV; Fig-
ures 1 and 2B).
By Gene Set Enrichment Analysis (GSEA), with a false discov-
ery rate (FDR) threshold of 0.25, most clusters were found to be
enriched for signatures of breast cancer-associated genes
(Tables S1–S6) and genes implicated in EMT, extracellular matrix
(ECM), metastasis, and cell migration (Figure 2C; Tables S1–S6).
GSEA of transcripts repressed early, late, or transiently (clusters
I–III) included gene sets associated with the repressive histone
mark H3K27Me3, genes downregulated in cell lines resistant to
therapeutic drugs, as well as gene targets of microRNAs (as
many as 20% of genes in clusters I and II; Figure 2C; Tables
S1–S6). Conversely, transcripts induced early, late or transiently
(clusters IV–VI) were enriched in GSEA gene sets associated with
cell migration, and in genes whose expression is downregulated
in response to HDAC1, HDAC2, and HDAC3 knockdown (Fig-
ure 2C; Tables S1–S6). Both induced and repressed gene clus-
ters included large numbers of transcriptional regulators (14%
of genes in cluster II, and 1%–6% of genes in clusters I and
III–VI), consistent with the presumed role of Snail-1 as a master
transcriptional regulator (Table S7). Thus, EMT initiation involveshors
Figure 1. Expression of Epithelial and
Mesenchymal Genes in Response to Snail-1
Induction
(A) Light-microscopic images of MCF10A cells
infected with ER-Snail-1S6A following exposure to
4-OHT for 24, 48, and 72 hr.
(B) Immunoblot of epithelial (CDH1 and CDH3) and
mesenchymal (FN1 and SERPINE1) markers in
response to 4-OHT treatment of ER-Snail-1S6A-
transduced cells. b-actin serves as loading con-
trol. V denotes parental noninfected MCF10A
cells.
(C) mRNA expression (qRT-PCR) of epithelial
(CDH1 and OCLDN) and mesenchymal (CDH2,
VIM, FN1, SERPINE1, and CTGF) genes 48 hr after
4-OHT-mediated induction of Snail-1. Error bars
represent SEM.
(D) mRNA expression (qRT-PCR) of epithelial
(CDH1 and OCLDN) and mesenchymal (FN1 and
SERPINE1) genes following 3, 6, 12, 24, 72, and
120 hr of 4-OHT. Error bars represent SEM.
(E) Mean trendline of epithelial (CDH1 and OCLDN)
and mesenchymal (FN1 and SERPINE1) gene
expression following Snail-1 expression.
(F) Real-time cell migration (Roche xCElligence
system) of Snail-1 transduced MCF10A cells in the
absence of 4-OHT (No OHT), upon 4-OHT expo-
sure at 0 hr (P0), and after 48 hr of pretreatment
with 4-OHT (P48).
See also Figure S1.the upregulation and downregulation of distinct functional
groups and pathways.
Transient Promoter Binding by Snail-1 during Induction
of EMT
The complex transcriptional patterns associated with induction
of Snail-1 expression may result from direct Snail-1 promoter
binding as well as secondary effects mediated by downstream
transcription factors. To define the time-dependent binding of
Snail-1 to its target promoters following its activation by
4-OHT, we first studied the prototypical CDH1 (epithelial) and
Vimentin (mesenchymal) promoters (time points: 0, 3, 6, 24, 48,
72, and 120 hr). Remarkably, Snail-1 binding to the CDH1
promoter was transient, despite continued Snail-1 protein
expression. Snail-1 binding was evident by 3 hr postinduction
(p value % 0.001 compared with time point 0 hr) and it disap-
peared by 48 hr (Figure 3A). In contrast, no incremental change
in Snail-1 binding was evident at the Vimentin promoter, sug-Cell Reports 5, 1679–1689, Degesting that its activation may be the
indirect consequence of transcriptional
intermediates (Figure 3A).
We next applied genome-wide chro-
matin immunoprecipitation (ChIP)-chip
analyses to extend the Snail-1-binding
studies to a broad set of target promoters
at multiple time points following Snail-1
induction (time points: 0, 6, 48, and
120 hr). By analyzing paired ChIP-chip
measurements with matched microar-rayed expression clusters, we found that Snail-1 binding was
evident in proximal promoter regions (2 kb to +2 kb with
respect to the transcriptional start site [TSS]) between 6 to
48 hr, with loss of Snail-1 enrichment at 120 hr (Figures 3B and
S2A). This transient Snail-1 enrichment was observed for 60%
of early-repressed genes (cluster I) and 45% of late-repressed
genes (cluster II; Figure 3B; Table S8). Surprisingly, given
Snail-1’s presumed function as a transcriptional repressor,
Snail-1 binding was also observed for up to 39% of early-
induced gene promoters (cluster IV; peak binding 48 hr) and up
to 32% of transiently induced transcripts (cluster VI; Figure 3B;
Table S8). In contrast, late-induced genes (cluster V) did not
show significant enrichment for Snail-1 binding, consistent with
indirect transcriptional regulation.
To confirm that transient binding of Snail-1 to its target pro-
moters is correlated with their respective gene expression,
transcripts in all clusters (I–VI) were binned according to expres-
sion level and plotted against the density of promoter-boundcember 26, 2013 ª2013 The Authors 1681
Figure 2. Dynamic Gene-Expression Pat-
terns Associated with Acute Induction
of EMT
(A) PCA plot of microarray-based expression
profiling for MCF10A Snail-1-induced cells (time
points: 3, 6, 12, 24, 72, and 120 hr; each time point
is normalized to its respective control (untreated)
time point).
(B) Clusters I–III represent early-, late-, and tran-
siently repressed genes, respectively. Clusters
IV–VI are early-, late-, and transiently induced
genes, respectively. Black and red lines represent
untreated and Snail-1-induced MCF10A cells,
respectively.
(C) GSEA-derived pathways identified as enriched
within individual gene-expression clusters through
a gene set signature. Individual GSEA gene sig-
natures and classifications are shown in Tables
S1–S6.
See also Table S7.Snail-1 at 6 hr (enrichment for Snail-1) and 120 hr (loss of Snail-1
enrichment). Early- and late-repressed clusters (clusters I and II)
revealed a linear relationship between the logarithm of ex-
pression and density of Snail-1 binding at 6 hr (Figure 3C).
No such relationship was detected at 120 hr, when Snail-1 pro-
moter binding is no longer enriched (Figure S2B). Early- and
transiently induced genes (clusters IV and VI) also revealed a
linear relationship between target gene expression and Snail-1
promoter binding density (Figures 3C and S2B). Together,
these observations suggest that a relatively brief promoter
occupancy by Snail-1 is sufficient to trigger long-term tran-
scriptional changes associated with a sustained mesenchymal
phenotype. In addition, a subset of induced genes show direct1682 Cell Reports 5, 1679–1689, December 26, 2013 ª2013 The Authorspromoter binding by Snail-1, suggesting
that it can function as an activator, as
well as a repressor, of its direct target
genes.
Sustained Chromatin Marks at
Snail-1-Regulated Promoters
To test whether Snail-1 binding is
associated with time-dependent chro-
matin modifications, we measured log2
ratio changes in the chromatin marks
H3K4Me1, H3K4Me2, H3K4Me3,
H3K27Me3, H3K4Ac, and H3K27Ac, all
within 2 kb to +2 kb of the TSS for
Snail-1 regulated transcripts (Figures
S3A–S3F and S4A–S4F). Multiple time
points (0, 6, 48, and 120 hr) following
Snail-1 induction were assayed using
ChIP-chip and confirmed using ChIP-
quantitative PCR (ChIP-qPCR) experi-
ments for selected targets (CDH1 and
VIM; Figures S3A–S3F). Given the
dynamic nature of gene-expression
changes observed during the initiationof EMT, we grouped the histone modifications within each
expression cluster (I–VI). Genes that are rapidly silenced upon
EMT initiation (cluster I) showed a loss of active marks
(H3K4Ac, H3K27Ac, and H3K4Me3) while gaining the repres-
sive H3K27Me3 modification. Enrichment of H3K4Me1 was
observed gradually over the course of EMT (Figure 4A). Genes
that were silenced >24 hr after induction of Snail-1 (cluster II)
showed a similar loss of active marks (H3K4Ac and
H3K4Me3) and gain of the repressive mark H3K27Me3 (Fig-
ure 4A). In contrast, transiently repressed genes (cluster III)
showed coincident loss of both active H3K4Ac and inactive
H3K27Me3 repressive marks, without changes in H3K27Ac
and H3K4Me3 (Figure 4A).
Figure 3. Transient Binding of Snail-1 to Its
Target Promoters
(A) ChIP-qPCR analysis of Snail-1 versus IgG
control at the CDH1 and VIM promoters at 0, 3, 6,
24, 48, 72, and 120 hr after addition of 4-OHT. *p%
0.001. Error bars represent SEM.
(B) ChIP-chip log2 ratio of Snail-1 immunoprecipi-
tation at 0, 6, 48, and 120 hr after 4-OHT addition.
Promoter sequences span from 2 kb to +2 kb of
TSS, and these are shown for early-, late-, and
transiently repressed genes (clusters I–III) and
early-, late-, and transiently induced genes (clus-
ters IV–VI). *p % 0.05, **p % 0.01, and ***p %
0.001. Red, green, and blue colors represent 6, 48,
and 120 hr compared with the 0 hr time point,
respectively.
(C) Correlation between Snail-1 promoter binding
and specific gene expression at the 6 hr time point.
Genes were sorted into 20 equal-size bins based
on expression levels (log2 GE), with the average of
Snail-1 ChIP-chip (log2 ChIP) intensity at pro-
moters and expression levels shown for each bin.
The Spearman p value is shownwithin each cluster
(Nie et al., 2012).
See also Figure S2 and Table S8.Promoters of genes induced early following Snail-1 induction
(cluster IV) showed gains of the active H3K4Me3 mark and of
H3K4Me1, together with loss of the repressive H3K27Me3
mark (Figure 4B), whereas late-induced genes (cluster V)
showed primarily loss of H3K27Me3 (Figure 4B). Chromatin
changes for transiently induced genes (cluster VI), including
H3K27Ac, H3K27Me3, and H3K4Me3, were themselves tran-
sient (Figure 4B). Overall, promoters of Snail-1-induced tran-
scripts showed more heterogeneous chromatin changes
compared with promoters of Snail-1-repressed genes, consis-
tent with the former having more indirect and potentially diverse
epigenetic mechanisms. Of note, the timeline of both activating
and repressive chromatin marks was delayed compared with
the initial Snail-1 promoter binding and early transcriptional
changes. Thus, direct transcriptional regulation by Snail-1 may
precede the deposition of classical chromatin silencing and acti-
vating marks that ultimately maintain the mesenchymal state
after Snail-1 has been released from its target promoters.Cell Reports 5, 1679–1689, DeSuppression of Induction and
Maintenance of EMT by Small-
Molecule Inhibitors of Chromatin
Regulators
The apparent role of chromatin modifica-
tions in the fixation of EMT raised the
possibility that inhibition of selected path-
ways might be capable of modulating this
phenotype. Given the observed correla-
tion between Snail-1-mediated repres-
sion and loss of H3K4Ac and H3K27Ac,
along with the number of HDAC targets
(HDAC1, HDAC2, and HDAC3) among
the Snail-1-regulated transcripts, we first
tested the effect of individual HDACgene knockdown (Figures 5A and S5A). siRNA-mediated knock-
down of either HDAC1 or HDAC3 reduced mesenchymal gene
induction by Snail-1 (Figures 5A and S5A). Knockdown of
HDAC2 had no effect on mesenchymal gene induction, and
none of the HDAC knockdowns significantly affected epithelial
gene repression by Snail-1. A very modest reduction in
CDH1-specific suppression by Snail-1 was observed following
HDAC1 knockdown, as previously reported (Peinado et al.,
2004; Figure 5A).
To extend our studies to the larger family of HDACs and other
chromatin modifiers, we turned to class-specific small-molecule
inhibitors and tested their effect on both the induction and main-
tenance of EMT. Cells were initially pretreated for 24 hr with
inhibitors, which were then maintained in the culture medium
as EMT was induced with 4-OHT for 48 hr. Induction of EMT
by Snail-1 was not affected by pretreatment of cells with the
DNA methylation inhibitor 5-azacytidine or the SIRTUIN inhibitor
nicotinamide (Figures 5B and S5B). However, pretreatment ofcember 26, 2013 ª2013 The Authors 1683
Figure 4. Transient and Sustained Snail-1-
Induced Chromatin Marks Associated with
Gene-Expression Clusters
(A and B) ChIP-chip log2 heatmap of Snail-1,
H3K4Ac, H3K27Ac, H3K4Me1, H3K4Me2,
H3K4Me3, and H3K27Me3 immunoprecipitates at
6, 48, and 120 hr compared with 0 hr after Snail-1
induction. Heatmap results are shown for 2 kb
to +2 kb promoter regions of genes whose
expression is altered by Snail-1: early- (cluster I),
late- (cluster II), and transiently (cluster III)
repressed transcripts; and early- (cluster IV), late-
(cluster V), and transiently (cluster VI) induced
transcripts.
See also Figures S3 and S4.cells with either the LSD1/LSD2 inhibitor Tranylcypromine (TCP)
or the HDAC class I and II inhibitor Trichostatin A (TSA)
attenuated both Snail-1-mediated downregulation of epithelial
markers and upregulation of mesenchymal markers (Figures
5B, S5B, and S6A). Combined treatment with TCP and TSA
completely abrogated EMT (Figures 5B and S5B). To test
whether this inhibitory effect on the initiation of Snail-mediated
EMT was shared with other triggers of EMT, we tested these in-
hibitors in cells exposed to TGF-b for 48 hr. Pretreatment of
cells with TSA and TCP was even more potent in inhibiting
TGF-b-induced EMT marker expression (Figures 5C and
S5C). Although the precise specificity of small-molecule inhibi-
tors is not fully characterized, we tested more selective inhibi-
tors, including SAHA (Vorinostat, an HDAC1, HDAC2, HDAC3,
and HDAC9 inhibitor), LBH589 (Panobinostat, an HDAC1,
HDAC2, HDAC3 and HDAC6 inhibitor), pargyline (an LSD1
inhibitor), Tubastatin A (an HDAC6 and HDAC8 inhibitor),
MS-275 (Entinostat, an HDAC1 and HDAC3 inhibitor), and
PXD101 (Belinostat, an HDAC inhibitor). Pargyline and
LBH589 fully abrogated Snail-1-induced EMT, whereas SAHA
selectively abolished mesenchymal gene induction (Figures
5D and S5D). MS-275 and PXD101 had only modest effects
on mesenchymal markers, and Tubastatin A was ineffective
(Figures 5D and S5D). Thus, although drug-specific differences1684 Cell Reports 5, 1679–1689, December 26, 2013 ª2013 The Authorswere apparent, HDAC and LSD1/LSD2
inhibitors can suppress the induction
of EMT.
To test whether HDAC inhibitors can
reverse established EMT, we induced
Snail-1 expression for 6 days and then
added chromatin inhibitors for 24 hr.
Remarkably, TSA alone mediated almost
complete reversion of mesenchymal
gene expression while also triggering a
modest reversal in epithelial gene repres-
sion (Figures 5E and S5E). Similarly, EMT
established by 12 days of TGF-b expo-
sure was largely abrogated upon TSA
treatment (Figures 5F and S5F). No
change in EMT established by Snail-1
or TGF-b was observed following treat-
ment with 5-azacytidine, nicotinamide,or TCP. Together, these observations support an important
role for chromatin modifications in both the establishment and
maintenance of EMT. Moreover, these results indicate that
TCP (an LSD1/LSD2 inhibitor) can attenuate the induction of
EMT, whereas HDAC inhibitors (e.g., TSA) can inhibit both the
induction and maintenance of EMT.
Having tested the effect of small-molecule inhibitors in a short-
term assay of Snail-1- and TGF-b-mediated EMT in nontrans-
formed MCF10A cells, we turned to established human breast
cancer cells that had undergone EMT during tumorigenesis.
We treatedMCF7 and triple-negative (TN; lacking ER, progester-
one receptor, and human epidermal growth factor receptor 2
expression) breast cancer cells with mesenchymal (M) features
(MDA-MB-231, BT549, and Hs578T) or basal (B) features
(MDA-MB-468 and HCC1937) with small-molecule inhibitors
(Figures 6A, S6B, and S6C). Three of the five cell lines (MDA-
MB-468, BT549, and HCC1937) showed suppression of mesen-
chymal gene expression following treatment with TSA, MS-275,
or LBH589, and the other two (MDA-MB-231 and Hs578T) had a
more modest reduction in mesenchymal gene expression (Fig-
ures 6A, S6B, and S6C). Almost no change in epithelial gene
expression was observed following drug treatment (Figure S6C).
Although the magnitude of the changes in EMT markers was not
as pronounced as that seen in MCF10A breast epithelial cells
Figure 5. Suppression of EMT by Small-Molecule Inhibitors of Chromatin Regulators
(A) Changes in expression of epithelial (CDH1 and OCLDN) and mesenchymal (FN1 and SERPINE1) genes 48 hr after Snail-1 induction in cells with RNAi
knockdown of HDAC1, HDAC2, or HDAC3. siRNA transfection was performed 24 hr prior to 4-OHT addition (see data in Figure S5A). Error bars represent SEM.
(B) Epithelial and mesenchymal gene expression induced by Snail-1 following treatment of cells with small-molecule inhibitors of chromatin regulators. Drugs
were added to cells 24 hr prior to 4-OHT treatment and maintained for another 48 hr. Error bars represent SEM.
(C) Effect of small-molecule inhibitors of chromatin regulators on TGF-b-induced (48 hr) EMT. Drugs were added 24 hr before initiation of treatment with TGF-b.
Error bars represent SEM.
(D) Effect of selective small-molecule inhibitors on Snail-1-mediated EMT. Drugs were added to cells 24 hr prior to 4-OHT treatment and maintained for another
48 hr. Error bars represent SEM.
(E) Reversibility of established Snail-1-induced EMT (6 days with 4-OHT) by treatment of cells with small-molecule inhibitors for 24 hr. Error bars represent SEM.
(F) Reversibility of established TGF-b-induced EMT (12 days with TGF-b) following 24 hr treatment with inhibitors. Error bars represent SEM.
See also Figures S5 and S6.acutely exposed to Snail-1 or TGF-b, these observations point to
a significant degree of reversibility in mesenchymal cell fate even
in established tumor cell lines. Moreover, in three of these five
triple-negative breast cancer lines, the reduction in mesen-
chymal markers was associated with a rapid and profound
decline in cellular motility (Figure 6B).
DISCUSSION
We have shown that Snail-1 triggers sustained but reversible
epigenetic changes, leading to mesenchymal transformation
in nontransformed human breast epithelial cells. Even when
induced continuously, Snail-1 binds only transiently (6–48 hr) to
its target repressed promoters with loss of activation marks
and gain of chromatin silencing marks being detectable afterCell ReSnail-1 itself is no longer immunoprecipitated from its target pro-
moters. Together, these observations support the concept of
EMT induction as an epigenetic switch, a model that is sup-
ported by the effectiveness of HDAC inhibitors in abrogating its
induction andmaintenance. Given the rapidly expanding number
of small-molecule inhibitors, with increasing specificity in tar-
geting individual components of the chromatin remodeling
machinery, these studies raise the possibility of ultimately sup-
pressing the mesenchymal phenotype associated with cancer
invasion and metastasis.
The role of Snail-1 as a master transcriptional regulator medi-
ating EMT is well established (Batlle et al., 2000, Cano et al.,
2000, Herranz et al., 2008, Lin et al., 2010, Peinado et al., 2004)
and our analysis provides a comprehensive timeline of tran-
scriptional outputs following Snail-1 activation (Tables S1–S7).ports 5, 1679–1689, December 26, 2013 ª2013 The Authors 1685
Figure 6. Suppression of Mesenchymal
Markers and Migration by Small-Molecule
Inhibitors in Triple-Negative Cancer Lines
(A) Reversibility of mesenchymal markers in
established cancer cell lines (triple-negative breast
cancer) following treatment with small-molecule
inhibitors for 24 hr. Expression of mesenchymal
(FN1, SERPINE1, and VIM) genes were assayed
(Fluidigm qRT-PCR) at 24 hr. *p% 0.05. Student’s
t test for mean of mesenchymal gene markers,
for each drug-treated cell line compared with
control DMSO-treated cell line (data in Figures
S6B and S6C).
(B) Real-time cell migration (Roche xCElligence
system) of HCC1937, MDA-MB-231, and Hs578T
following treatment (24 hr) with and without TSA.
Migration of BT549 and MDA-MB-468 is not
shown because there was minimal effect.
See also Figure S6.Binding of Snail-1 to the promoters of down- or upregulated gene
transcripts was evident for many, but not all, targets, pointing to
both direct and indirect effects within a cascade of downstream
transcriptional effectors. While Snail-1 is thought to function
primarily as a transcriptional repressor, we did observe Snail-1
binding to a subset of upregulated gene promoters, raising the
possibility that these promoters may be directly transcriptionally
activated by Snail-1. Such an effect might reflect promoter
context and recruitment of associated cofactors, including
HDAC1, HDAC2, and SIN3A. Of note, ChIP-chip studies have
suggested that in developing Drosophila embryos, Snail-1 may
act as both a transcriptional activator and repressor (Zeitlinger
et al., 2007). Given the long-lasting effects of Snail-1 on its tran-
scriptional targets, the fact that it binds to target promoters
only transiently was unexpected. The determinants of this tran-
sient binding activity are unclear, and could involve the recruit-
ment of additional cofactors that release Snail-1 from its binding
site, or alternatively the Snail-1-induced chromatin changes
could themselves reduce binding by Snail-1. Similar transient
promoter binding characteristics have been described for
c-Myc in the context of cellular reprogramming to generate
induced pluripotent stem cells, as well as during cell-cycle pro-
gression (Brambrink et al., 2008, Sridharan et al., 2009, Swarna-
latha et al., 2012).
In this work, we analyzed chromatin changes triggered by
Snail-1 in conjunction with early, late, and transient transcrip-
tional changes. We found loss of H3K4Me3, H3K4Ac, and
H3K27Ac, and gain of H3K27Me3 for genes repressed during
EMT. Among the genes activated by Snail-1, themost consistent
pattern was observed for those induced early, which showed
gain of H3K4Me3 and H3K4Me1, and loss of H3K27Me3. Such
chromatin changes are consistent with a programmed epige-
netic switch linked to EMT. Indeed, constitutive expression of
Snail-1 in trophoblast stem cells results in global loss of acetyla-1686 Cell Reports 5, 1679–1689, December 26, 2013 ª2013 The Authorstion on histones H2A andH2B (Abell et al.,
2011), and hypoxia-induced EMT has
been linked to H3K4 deacetylation at
epithelial genes and H3K4 methylationat mesenchymal genes (Wu et al., 2011). In addition, TGF-
b-mediated EMT appears to reduce H3K9Me2 and increase
H3K4Me3 within large heterochromatin domains (LOCKs), with
increased H3K36Me3 at LOCK boundaries (McDonald et al.,
2011). Building on these observed EMT-associated changes in
chromatin, our ability to acutely trigger Snail-1-mediated EMT
and correlate promoter chromatin marks with time-dependent
global transcriptional patterns thus provides a comprehensive
view of the differential changes affecting a broad array of func-
tionally related genes.
Considerable advances have recently beenmade in the gener-
ation of small-molecule inhibitors of chromatin regulators, raising
the possibility of targeting chromatin processes for therapeutic
intervention. Although the specificity of these inhibitors remains
suboptimal and the physiological properties of their gene targets
are incompletely understood, they provide critical tools to probe
the functional consequences of disrupting subsets of chromatin
modifications. Some of these inhibitors, such as SAHA and
Vorinostat, have already been approved to treat cutaneous
T cell lymphoma, and other HDAC inhibitors are currently in
clinical trials. Given the redundancy of chromatin regulators,
small-molecule inhibitors suppress large subsets of these gene
families, and our initial analyses will need to be refined as further
specific inhibitors become available. Nonetheless, the observed
synergy betweenHDAC and LSD1/LSD2 inhibitors suggests that
suppressing the removal of H3K4Me1, H3K4Me2, and histone
acetylation marks is sufficient to preserve an active chromatin
configuration at key promoters targeted by the Snail-1 transcrip-
tional repressor, thus abrogating EMT. The potent effect of
HDAC inhibitors may reflect both derepression of epithelial
genes and potentially indirect repression of mesenchymal genes
(Jordaan et al., 2013,Mariadason et al., 2000, Gryder et al., 2012,
Wagner et al., 2010). In our study, we observed inhibitory effects
of TCP and TSA with both Snail-1 and TGF-b-induced EMT,
leading to dramatic suppression of both initiation and mainte-
nance of this phenotype. The effect of these small-molecule in-
hibitors on established cancer cell lines, whose mesenchymal
properties emerged during tumorigenesis and were maintained
for prolonged periods of time in culture, was more modest but
nonetheless remarkable. A significant reduction of tumor cell
migration was associated with drug treatment, raising the possi-
bility of modifying such properties in established cancer cells.
In summary, our study lays a foundation for understanding the
transcriptional landscape of EMT initiation by amaster transcrip-
tional regulator. In addition to providing evidence supporting an
epigenetic mechanism for the induction and maintenance of
EMT, our analysis points to potential therapeutic approaches
to modulate this phenotype, which is implicated in cancer inva-
sion and metastasis.
EXPERIMENTAL PROCEDURES
Tissue Culture and Plasmids
MCF10A cells were cultured as described previously (Debnath et al., 2003).
Recombinant human TGF-b1 was obtained from R&D Systems. The human
Snail-1 open reading frame with six serine to alanine mutations (Zhou et al.,
2004) was fused with modified ER and cloned into the PBABEpuro retroviral
expression vector. Retrovirus packaging, MCF10A transduction, and puromy-
cin selection were performed as described previously (Zhang et al., 2008). For
real-time migration measurements, AceaE-plates and CIM-plates 16 were
used with an xCELLigence system. Following a 1 hr background measure-
ment, cells were seeded (50,000 cells/100 ml well) and the impedance was
monitored continually for 24 hr.
Immunoblot Analysis and qRT-PCR Analyses
Cells were harvested in 13 RIPA buffer containing 13 protease inhibitor cock-
tail (Complete EDTA-free; Roche). Cell lysates were cleared by centrifugation
at 14,000 rpm for 10 min at 4C. For immunoblotting analysis, lysates were
loaded onto 4%–15%SDS-PAGE gels (ReadyGel; Bio-Rad) and subsequently
transferred onto Immobilon PVDF membrane (Millipore). Proteins were visual-
ized with the Western Lightning Plus chemiluminescence kit (PerkinElmer).
The following antibodies were used: CDH1 (610181; BD Biosciences), CDH3
(610227; BD Biosciences), SERPINE1 (612024; BD Biosciences), FN1
(F3648; Sigma-Aldrich), b-actin (ab6276; Abcam), and Flag (Sigma-Aldrich).
For real-time qPCR analyses, RNA was extracted using the RNeasy Mini kit
(Qiagen) and cDNA synthesis was performed using SuperScript III reverse
transcriptase (Invitrogen). Epithelial and mesenchymal genes were expressed
at sufficient levels, thus permitting reliable qPCR quantitation using the Power
SYBR Green PCR Master Mix (Applied Biosystems). All samples were done in
triplicate and the relative abundance was derived by standardizing the input to
the control signal, glyceraldehyde 3-phosphate dehydrogenase. The primer
sequences used for qRT-PCR are listed in Table S9.
RNAi Assays and Drug Treatments
A pool of four siRNAs targeting each HDAC1, HDAC2, and HDAC3 was used,
along with a nontargeting (control) siRNA from Dharmacon. RNAi transfection
was performed according to the manufacturer’s protocol. Knockdown of
HDAC1, HDAC2, HDAC3, and control were performed 24 hr prior to the addi-
tion of 4-OHT. Chemical inhibitor studies for Snail-1 or TGF-b induction exper-
iments were performed by treatment of cells with 50 mMTCP (Sigma-Aldrich) in
DMSO, 1 mM TSA (Sigma-Aldrich) in DMSO, 5 mM 5-azacytidine (Sigma-
Aldrich) in acetic acid/H2O (1:1 v/v), 10 mM nicotinamide (Sigma-Aldrich) in
H2O, 1 mM MS-275 (Selleck Chemicals) in DMSO, 1 mM LBH589 (Selleck
Chemicals) in DMSO, 1 mM PXD101 (Selleck Chemicals) in DMSO, 1 mM
SAHA (Selleck Chemicals) in DMSO, 1 mM Tubastatin A (Selleck Chemicals)
in DMSO, and 12.5 mM of Pargyline HCl (Sigma-Aldrich) in H2O for 24 hr, prior
to addition of 4-OHT for another 48 hr. Fresh inhibitor and 4-OHT was added
every 24 hr. RNA was extracted, cDNA was synthesized, and qRT-PCR wasCell Reperformed as described above. Paired vehicle controls were performed for
each drug target. Chemical inhibitor studies to test the reversibility of Snail-1
or TGF-b-induced EMT were done with the drug concentrations listed above,
and the chromatin inhibitors were added for 24 hr, following EMT induction
(6 days of Snail-1 induction or 12 days TGF-b pretreatment). The IC50 values
at 72 hr were as follows: TSA, 6 mM; LBH589, 1.6 mM;MS-275, 11.6 mM; Pargy-
line HCl, 50.64 mM; and TCP, cannot be determined.
ChIP and Gene Expression Arrays
For RNA expression analysis, RNA was extracted using the RNeasy Mini
kit (Qiagen). cDNA synthesis was performed using the Roche cDNA syn-
thesis system (11 117 831 001). cDNA was hybridized to Human Gene Expres-
sion 123135K Arrays (Roche Nimblegen) in triplicate according to the
manufacturer’s protocol. The following antibodies were used for ChIP ana-
lyses: Snail-1 (AF3639; R&D Systems), Total H3 (ab1791; Abcam), H3K4Ac
(07-539; Millipore), H3K27Ac (ab4729; Abcam), H3K4Me1 (ab8895; Abcam),
H3K4Me2 (ab11946; Abcam), H3K4Me3 (ab8580; Abcam), H3K27Me3
(ab6002; Abcam), and immunoglobulin G (IgG; 2729S; Cell Signaling). ChIP
was performed as described previously (Black et al., 2010). The primer
sequences used for ChIP-qPCR are listed in Table S9. ChIP-chip was per-
formed as described previously (Van Rechem et al., 2011). Snail-1, H3K4Ac,
H3K27Ac, H3K4Me1, H3K4Me2, H3K4Me3, and H3K27Me3 immunoprecipi-
tations were amplified with the WGA2 kit (Sigma-Aldrich). The amplified mate-
rial was hybridized to Human 2.1 M Deluxe HG18 Promoter Arrays (Roche
Nimblegen) in duplicates according to themanufacturer’s protocol. Themicro-
arrays were scanned on a Nimblegen MS200 at 2 mm resolution.
Statistical and Bioinformatic Analyses
All statistical and bioinformatics analyses were performed using R and the
Bioconductor software suite. RNA data were preprocessed by the robust
multi-array average (RMA) method (Irizarry et al., 2003). ChIP-chip data
were preprocessed using the Nimblegen method of the Ringo Bioconductor
package (Toedling et al., 2007), quantile normalized, and then smoothed by
the application of a 900 bp box filter. Differentially expressed genes (for
gene expression or ChIP) were identified for different comparisons using a
modified t test (Smyth, 2004) with correction for multiple testing using the
method of Benjamini and Hochberg (1995) (p % 0.05 for differential ChIP-
chip, p % 0.01 for differential gene expression). Hierarchical clustering using
correlation distances and the Ward method was performed on the change in
gene expression from each respective untreated time point for all genes found
to be differentially expressed at the respective treated time point to any
subsequent time (3, 6, 12, 24, 72, and 120 hr) for early-, late-, or transiently
induced genes, and early-, late-, or transiently repressed genes. Densities
were estimated using the density function in R with default parameters. We
verified random and known epithelial and mesenchymal genes in clusters I,
II, IV, and V. Clusters III and VI were not analyzed. Six out of six genes in clus-
ter I, two out of four genes in cluster II, and five out of five genes in cluster IV
were verified. For cluster V, all five genes selected had a delta CT > 35 and
were discarded.
GSEA
Enriched gene signatures were manually annotated for their functional cate-
gories for each cluster (group and subgroup; for specifics, see Tables S1–
S6). For each cluster, the top 100 gene sets were analyzed. If a cluster
contained <100 gene sets, all gene sets in that cluster were analyzed. Data
are summarized in Figure 2C.
Calculating the Cutoff for Snail-1 Enrichment
For time t and gene g, let St,g be the average of the log2 of the Snail-1 ChIP-chip
data in a region 2,500 bp on either side of the TSS of the gene. Let It,g be the
same for the input DNA. Let Dt,g = (St,g – It,g) – (S0,g – I0,g). For t = 6, 48, and
120 hr, we plotted an estimate of the density (i.e., the histogram one would
get if one had infinitely many data points and infinitely thin bins) of the Dt,g
for the genes in each of the six clusters.
Determining Genes Enriched for Snail-1
Given that at time 120 hr, the densities of all the clusters are symmetric and
centered at zero, we concluded that there is no significant additional binding
of Snail-1 at 120 hr compared with 0 hr. Thus, densities at 120 hr were used
as a null distribution in the following way: let Y be the 95th percentile of allports 5, 1679–1689, December 26, 2013 ª2013 The Authors 1687
the D120,g. Gene g has significantly more Snail-1 binding at time t than at
time 0 if Dt,g is greater than Y.
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